Sarepta Therapeutics

+$3.40 (+4.73%) Today
$0.00 (0.00%) As of 11:06 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO
Douglas S. Ingram
Employees
840
Headquarters
Cambridge, Massachusetts
Founded
1980

SRPT Key Statistics

Market cap
6.58B
Price-Earnings ratio
—
Dividend yield
—
Average volume
720.58K
High today
$75.46
Low today
$70.50
Open price
$70.55
Volume
1.74M
52 Week high
$101.24
52 Week low
$61.28

SRPT News

CNBCJun 23

Stocks making the biggest moves after hours: FedEx, Sarepta Therapeutics and more - CNBC

Engineers move a 350-volt battery pack to be installed in a Fedex Corp. Express General Motors Co. (GM) van at the VIA Motors Inc. facility in Orem, Utah, U.S.
BenzingaJun 23

Sarepta Therapeutics' Shares Plummet Following FDA's Clinical Hold On MOMENTUM Study

The U.S. Food and Drug Administration (FDA) has placed a clinical hold on SRP-5051 (vesleteplirsen), Sarepta Therapeutics' SRPT lead candidate to treat patients
Simply Wall StJun 20

Insiders may be rethinking their US$2.3m Sarepta Therapeutics, Inc. investment now that the company has lost US$191m in value - Simply Wall St

Insiders who bought US$2.3m worth of Sarepta Therapeutics, Inc.'s ( ) stock at an average buy price of US$79.86 over the last year may be disappointed by the re

SRPT Earnings

-$1.89
-$1.26
-$0.63
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure